01298nam 2200361Ia 450 991069696330332120230902162114.0(CKB)5470000002383258(OCoLC)540607620(EXLCZ)99547000000238325820100305d2008 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry and review staff[electronic resource] nonclinical safety evaluation of reformulated drug products and products intended for administration by an alternate routeRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,[2008]1 electronic resource (8 pages)"Draft guidance.""Pharmacology/Toxicology.""March 2008."Guidance for industry and review staff DrugsUnited StatesTestingDrugsTesting.Center for Drug Evaluation and Research (U.S.)GPOGPOGPOBOOK9910696963303321Guidance for industry and review staff3444689UNINA